Crossref
RET in the Genomic Era: Moderate Risk Has Become the Majority
Clinical Thyroidology® · 01.03.2026 · 38 (3) · 80-83
DOI: 10.1177/23299711261436481 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Thyroidology®, online erschienen am 22.04.2026. Verfasst von Elizabeth E. Cottrill. Die Arbeit nennt 9 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Cottrill, E. E. (2026). RET in the Genomic Era: Moderate Risk Has Become the Majority. Clinical Thyroidology®, 38(3), 80-83. https://doi.org/10.1177/23299711261436481
Vancouver
Cottrill EE. RET in the Genomic Era: Moderate Risk Has Become the Majority. Clinical Thyroidology®. 2026;38(3):80-83. doi:10.1177/23299711261436481
BibTeX
@article{Cottrill2026,
author = {Cottrill, Elizabeth E.},
title = {RET in the Genomic Era: Moderate Risk Has Become the Majority},
journal = {Clinical Thyroidology®},
year = {2026},
volume = {38},
number = {3},
pages = {80--83},
doi = {10.1177/23299711261436481}
}
EUVIMED